Combivent HFA Inhalation Aerosol

· Boehringer Ingelheim

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Combivent HFA Inhalation Aerosol, covering 2018-08-31 to 2018-08-31. Get the full timeline:

Most recent: Clinical Trial Update: A Confirmation Study of Combivent HFA Inhalation Aerosol in Patients With Chronic Obstructive Pulmonary Disease (COPD) [Phase 2]

See pricing